Instacart's stock slips after IPO, Dollar General shares hit by downgrade and other stocks on the move
By MarketWatch
Textron is leading S&P 500 gainers after an order for up to 1,500 Cessna business jets
Here are the day's biggest movers:
Stock gainers:
Shares of Steelcase Inc. (SCS) gained 27% after the office-furniture maker called for "significantly improved" profit as more companies order their employees back to the office.
Pinterest Inc.'s (PINS) stock rose 4.7% after company executives said they expect revenue growth to pick up in 2024 after a slowdown in 2023 and 2022. The company also added former eBay Inc. (EBAY) executive Scott Schenkel to its board and announced a slew of new ad tech tools at its investor day.
Textron Inc.'s stock (TXT) rose 5% to lead S&P 500 gainers, after the aviation company announced an agreement with NetJets for up to 1,500 additional Cessna Citation business jets over the next 15 years.
Nio Inc.'s stock (NIO) rose 3%, a day after they suffered their worst day in four years, and their third-worst day since going public in September 2018, in the wake of the China-based electric vehicle maker's announcement of a $1 billion convertible bond offering.
Goldman Sachs Group Inc.'s stock (GS) rose 0.4%, after the Wall Street Journal said the bank is in advanced talk with a group of investment firms, which includes KKR (KKR), Sixth Street and Pacific Investment Management, on the sale of its GreenSky specialty loan unit.
Stock decliners:
Shares of Instacart (CART) were down 4.5% following a debut in which they finished up 12%. A Needham analyst initiated coverage of the stock with a hold rating and said he sees various "structural headwinds against adoption," after some survey respondents indicated enjoyment of in-store shopping and concerns about getting the right products.
Dollar General stock (DG) fell 2%. JPMorgan slashed its rating on the retailer to underweight from neutral, and cut its price target to $116 from $132, following comments made by CFO Kelly Dilts at a conference the investment bank held in London. JPMorgan is now forecasting flat comparable-store sales growth, as Dollar General's core low income customer is "acting recessionary today."
Canopy Growth Corp.'s stock (CGC) (CA:WEED) slid 8.7%, after the Canadian cannabis company registered about 46 million shares for sale to the public. The filing comes two days after the company announced a private placement with institutional investors of up to $50 million to boost liquidity.
General Mills Inc.'s stock (GIS) slid 0.3%, after the consumer-foods company posted slightly better-than-expected fiscal first-quarter earnings, but said the consumer is still wary in an uncertain economic climate.
Sharesof ARS Pharmaceuticals Inc. (SPRY) tumbled 57%, after the biopharmaceutical company said the U.S. Food and Drug Administration issued a Complete Response Letter regarding the New Drug Application for its epinephrine nasal spray Neffy.
Seelos Therapeutics Inc.'s stock (SEEL) tanked 75%, after the company reported promising results from a trial of a treatment for Acute Suicidal Ideation and Behavior (ASIB) in adults with Major Depressive Disorder (MDD) but said a too-small sample size means the study did not meet its primary endpoint.
-MarketWatch
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-20-23 1228ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks